Wahia Tasnim | Pulmonary Hypertension | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Best Researcher Award

Wahia Tasnim
Best Researcher Award, Bangladesh

Wahia Tasnim
Affiliation Best Researcher Award
Country Bangladesh
Scopus ID 58930601500
Documents 10
Citations 84
h-index 3
Subject Area Pulmonary Hypertension
Event International Research Awards on Cardiology & Cardiovascular Medicine
ORCID 0000-0001-8339-2043

Wahia Tasnim is recognized in this academic profile as a researcher associated with the subject area of pulmonary hypertension and cardiovascular medicine. The available bibliometric information records 10 documents, 84 citations, and an h-index of 3, providing a concise quantitative view of publication activity and scholarly citation impact. These indicators are considered alongside subject relevance and research contribution when assessing suitability for an academic recognition program in cardiology and cardiovascular medicine. [1]

Abstract

Wahia Tasnim is presented as a researcher working within pulmonary hypertension, a clinically significant field connecting pulmonary vascular disorders with cardiovascular health. The available research profile reports 10 Scopus-indexed documents, 84 citations, and an h-index of 3. These indicators provide evidence of a developing scholarly record and measurable citation activity. Within the context of the International Research Awards on Cardiology & Cardiovascular Medicine, the researcher’s subject alignment with pulmonary hypertension offers a relevant basis for academic consideration. Evaluation should incorporate documented publications, research quality, citation performance, originality, clinical relevance, and broader contributions to cardiovascular research and scientific communication. [1] [2]

Keywords

Wahia Tasnim, Best Researcher Award, pulmonary hypertension, cardiovascular medicine, cardiology, pulmonary vascular disease, cardiovascular research, Scopus, research impact, scholarly communication.

Introduction

Pulmonary hypertension encompasses a group of disorders characterized by elevated pressure within the pulmonary circulation and may involve complex interactions between pulmonary vascular and cardiac systems. Research in this area contributes to understanding disease mechanisms, diagnosis, risk assessment, and therapeutic strategies. [3] For an academic recognition program focused on cardiology and cardiovascular medicine, research addressing pulmonary vascular disease is directly relevant because of its close relationship with right-heart function, cardiovascular physiology, and patient outcomes.

Research Profile

The available bibliometric profile for Wahia Tasnim records 10 documents and 84 citations, with an h-index of 3. Scopus bibliometric indicators are commonly used to describe publication output and citation-based visibility, although they do not independently establish research quality or clinical significance. [1] The profile therefore provides a quantitative foundation for considering the researcher’s scholarly activity while recognizing the importance of qualitative assessment.

Research Contributions

The principal subject association identified for Wahia Tasnim is pulmonary hypertension. Research in this field can contribute to cardiovascular medicine through improved understanding of pulmonary vascular remodeling, right ventricular adaptation, hemodynamic assessment, and the clinical management of patients with pulmonary vascular disease. Contemporary guidance emphasizes multidisciplinary evaluation and appropriate classification of pulmonary hypertension to support accurate diagnosis and treatment decisions. [3] [4]

Publications

The supplied research profile indicates 10 scholarly documents indexed under Scopus author information. A publication record should be interpreted by considering the nature of each document, journal quality, authorship contribution, methodological rigor, subject relevance, and subsequent scholarly use. The available information does not provide a verified publication-by-publication bibliography; therefore, specific article titles, journals, publication years, and DOI identifiers should be confirmed directly through authoritative bibliographic records before being attributed to the researcher. [1]

Research Impact

The reported 84 citations indicate that the researcher’s indexed publications have received measurable scholarly attention. The h-index of 3 further reflects the relationship between publication output and citation distribution within the indexed record. Such metrics are useful for contextual assessment but should not be treated as complete measures of research quality, societal impact, clinical influence, or originality. [2] In cardiovascular research, broader impact may also be assessed through clinical applicability, collaboration, guideline relevance, education, and contribution to improved understanding of disease.

Award Suitability

Wahia Tasnim’s identified subject area of pulmonary hypertension provides a direct connection to cardiovascular and cardiopulmonary medicine. The reported research metrics establish a documented scholarly profile that may be considered within an award assessment framework. Suitability for the Best Researcher Award should ultimately be determined through transparent evaluation of the submitted research portfolio, originality, methodological quality, publication record, citations, professional contributions, and relevance to the objectives of the International Research Awards on Cardiology & Cardiovascular Medicine.

Conclusion

Wahia Tasnim has a documented research profile associated with pulmonary hypertension and cardiovascular medicine, with 10 reported documents, 84 citations, and an h-index of 3. These indicators provide a concise measure of scholarly activity and citation visibility. The researcher’s subject alignment with pulmonary hypertension makes the profile relevant to cardiovascular research recognition, while comprehensive award assessment should combine bibliometric evidence with qualitative evaluation of research originality, rigor, significance, and contribution to the field.

References

  1. Elsevier. (n.d.). Scopus author details: Wahia Tasnim, Author ID 58930601500. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=58930601500
  2. Journal article (2025). Integrative Machine Learning and Bioinformatics Approach for Identifying Key Biomarkers in Gallbladder Cancer Diagnosis and Progression.
    https://doi.org/10.1049/syb2.70022
  3. Journal article (2024). Comprehensive bioinformatics and machine learning analyses for breast cancer staging using TCGA dataset .
    https://doi.org/10.1093/bib/bbae628
  4. ORCID. (n.d.). ORCID: Connecting research and researchers. ORCID.
    https://orcid.org/0000-0001-8339-2043
  5. World Health Organization. (2026 ). Cardiovascular diseases. World Health Organization.
    https://cardiology-conferences.pencis.com/

Worku Tassew | Cardiovascular Researches | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Best Researcher Award

Worku Tassew
Teda Health Science College, Ethiopia

Worku Tassew
Affiliation Teda Health Science College
Country Ethiopia
Scopus ID 57258929800
Documents 57
Citations 111
h-index 6
Subject Area Cardiovascular Researches
Event International Research Awards on Cardiology & Cardiovascular Medicine
ORCID 0000-0001-7952-1738

Worku Tassew is a researcher affiliated with Teda Health Science College in Ethiopia whose scholarly record is associated with cardiovascular research. The researcher has a documented Scopus profile containing 57 documents, 111 citations, and an h-index of 6. These bibliometric indicators provide a quantitative overview of research productivity and citation impact within the indexed scholarly literature. [1]

Abstract

Worku Tassew is a researcher affiliated with Teda Health Science College, Ethiopia, with scholarly activity positioned within cardiovascular research. Available bibliometric information identifies 57 indexed documents, 111 citations, and an h-index of 6, providing measurable indicators of publication productivity and citation influence. The researcher’s subject classification in Cardiovascular Researches places the academic record within a field concerned with cardiovascular health, disease mechanisms, prevention, diagnosis, treatment, and related clinical research. This profile is considered in relation to the Best Researcher Award under the International Research Awards on Cardiology & Cardiovascular Medicine, using documented scholarly indicators and research relevance. [1]

Keywords

Worku Tassew; Cardiovascular Researches; Cardiology; Cardiovascular Medicine; Research Productivity; Citation Impact; Scholarly Publications; Bibliometrics; Teda Health Science College; Best Researcher Award.

Introduction

Cardiovascular research encompasses a broad scientific and clinical field addressing diseases and conditions affecting the heart and circulatory system. Contemporary cardiovascular scholarship includes epidemiology, prevention, diagnostics, therapeutic interventions, rehabilitation, cardiovascular risk factors, and translational research. Bibliometric measures such as documents, citations, and h-index are commonly used to describe aspects of scholarly productivity and citation influence, although they do not independently determine research quality. [2]

Research Profile

The available Scopus information records 57 documents associated with Worku Tassew, together receiving 111 citations and producing an h-index of 6. The document count indicates sustained indexed publication activity, while citations provide an observable measure of how published research has been referenced within subsequent scholarly literature. The stated subject area, Cardiovascular Researches, establishes the principal scholarly relevance of the profile to the International Research Awards on Cardiology & Cardiovascular Medicine. ORCID provides a persistent identifier that can assist in distinguishing a researcher from individuals with similar names and in connecting scholarly contributions across research systems. [3]

Research Contributions

For award assessment, research contributions can therefore be considered in conjunction with the researcher’s publication record, citation performance, subject alignment, and supporting evidence submitted for evaluation. Such a combined assessment provides a more balanced interpretation than reliance on any single bibliometric indicator. [4]

Publications

The Scopus record associated with Worku Tassew contains 57 indexed documents. This publication volume represents the documented scholarly output available through the supplied researcher profile. Publication counts can provide a useful indicator of research activity, but comparisons between researchers should account for differences in discipline, career stage, collaboration patterns, publication practices, and citation behavior. [1]A detailed assessment of individual publications should examine article subject matter, journal quality, study design, authorship role, methodological contribution, and relevance to cardiovascular research. Where individual publication records and DOI information are available, those primary records provide the appropriate basis for verifying publication details and research outputs.

Research Impact

The profile records 111 citations across 57 documents, with an h-index of 6. These figures indicate that the researcher’s publications have received measurable attention within the indexed scholarly literature. Citation counts can reflect research visibility and subsequent scholarly use, although citation behavior varies substantially among disciplines and publication types. Consequently, citation indicators are best interpreted as quantitative evidence rather than as a complete measure of scientific or clinical impact. [2]

Award Suitability

The Best Researcher Award profile is relevant to the International Research Awards on Cardiology & Cardiovascular Medicine because the supplied subject classification is Cardiovascular Researches and the documented publication record demonstrates indexed scholarly activity. The 57 documents, 111 citations, and h-index of 6 provide quantitative evidence that may support consideration of research productivity and scholarly influence. [1]Final award evaluation should consider the complete nomination materials, including the quality and relevance of publications, originality of research, methodological strength, documented contributions, research significance, and alignment with the award criteria. Bibliometric indicators can complement this assessment but should not be treated as the sole determinant of recognition.

Conclusion

Worku Tassew’s documented academic profile reflects research activity associated with Cardiovascular Researches at Teda Health Science College in Ethiopia. The available Scopus indicators of 57 documents, 111 citations, and an h-index of 6 provide a quantitative foundation for reviewing publication productivity and citation influence. [1] In the context of the Best Researcher Award, these indicators can be considered alongside the substantive quality, relevance, originality, and significance of the researcher’s cardiovascular research contributions.

References

  1. Elsevier. (n.d.). Scopus author details: Worku Tassew, Author ID 57258929800. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57258929800
  2. Journal article. (2026). Incidence and predictors of tuberculosis among adult diabetes mellitus patients in western Amhara comprehensive specialized hospitals, northwest Ethiopia. A multicenter retrospective follow-up study.
    https://doi.org/10.1177/22799036261451534
  3. ORCID. (n.d.). ORCID: Connecting research and researchers. ORCID.
    https://orcid.org/0000-0001-7952-1738
  4. Journal article. (2026). Companionship care and associated factors among childbirth women in Ethiopia: a systematic review and meta-analysis.
    https://doi.org/10.1177/26334941261434846
  5. World Health Organization. (2023). Cardiovascular diseases. World Health Organization.
    https://cardiology-conferences.pencis.com/

Andrea Pisesky | Congenital Heart Defects | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Best Researcher Award

Andrea Pisesky
Stollery Children’s Hospital

Andrea Pisesky
Affiliation Stollery Children’s Hospital
Country Canada
Scopus ID 57219721692
Documents 9
Citations 478
h-index 7
Subject Area Congenital Heart Defects
Event Cardiology and Cardiovascular Medicine
ORCID 0000-0003-0094-0193

Andrea Pisesky is a researcher affiliated with Stollery Children’s Hospital in Canada, with a documented research profile associated with congenital heart defects and cardiovascular medicine. The supplied bibliometric information records nine documents, 478 citations, and an h-index of 7. The profile also includes ORCID identifier 0000-0003-0094-0193, supporting persistent researcher identification. [1] [2]

Abstract

Andrea Pisesky is a researcher affiliated with Stollery Children’s Hospital in Canada whose documented scholarly profile focuses on congenital heart defects and cardiovascular medicine. The supplied bibliometric record identifies nine documents, 478 citations, and an h-index of 7 under Scopus author identifier 57219721692. These indicators provide a quantitative representation of documented research activity and citation visibility. The profile is additionally associated with ORCID identifier 0000-0003-0094-0193, supporting researcher identification and record disambiguation. This article presents the available academic information in a structured recognition profile, covering research orientation, contributions, publications, citation impact, and relevance to consideration for a Best Researcher Award within cardiovascular medicine.

Keywords

Andrea Pisesky, Best Researcher Award, congenital heart defects, cardiology, cardiovascular medicine, Stollery Children’s Hospital, Canada, Scopus, ORCID, research impact. [1] [2]

Introduction

Congenital heart defects are an important area of cardiovascular research because structural abnormalities of the heart and major vessels can require continuing clinical assessment and multidisciplinary management. Research in this field encompasses diagnosis, intervention, outcomes, epidemiology, and long-term care. Bibliographic databases such as Scopus provide standardized indicators that can assist in describing documented scholarly activity and citation performance. [1] [5]

Research Profile

The supplied profile places Andrea Pisesky within the research area of congenital heart defects and cardiovascular medicine, with an institutional affiliation at Stollery Children’s Hospital in Canada. The reported Scopus record contains nine documents, 478 citations, and an h-index of 7. ORCID identifier 0000-0003-0094-0193 provides an additional persistent identifier for researcher disambiguation. [1] [2]

Research Contributions

The documented subject focus is relevant to congenital cardiac conditions and cardiovascular medicine, disciplines that rely on clinical investigation, patient characterization, treatment evaluation, outcomes research, and interdisciplinary collaboration. Based on the supplied information, the research profile can be described within this broad domain without attributing specific scientific findings that are not independently established by the available publication record. [3]

Publications

The supplied Scopus information records nine documents associated with author identifier 57219721692. These documents constitute the reported scholarly output underlying the stated citation count and h-index. Publication-level details such as article titles, journals, dates, authorship, and DOI identifiers should be verified against the relevant bibliographic records before being used for detailed assessment. [1]

Research Impact

The reported bibliometric profile contains 478 citations and an h-index of 7. These measures provide quantitative indicators of citation activity associated with the supplied author record. Citation counts are dynamic and may change as databases are updated; consequently, bibliometric indicators should be considered alongside publication quality, research relevance, methodological contribution, and broader academic or clinical influence. [1]

Award Suitability

The available academic indicators provide relevant evidence for consideration within a researcher recognition framework focused on cardiology and cardiovascular medicine. The combination of documented scholarly output, citation activity, subject-area relevance, institutional affiliation, and persistent researcher identification can support an evidence-based nomination. Final eligibility and recognition should be determined according to the official criteria and review procedures of the organizing body. [4]

Conclusion

Andrea Pisesky’s supplied academic profile reflects research activity associated with congenital heart defects and cardiovascular medicine in Canada. The reported Scopus indicators of nine documents, 478 citations, and an h-index of 7 provide measurable evidence of documented scholarly visibility. Together with ORCID identification and institutional affiliation, these indicators form a structured basis for an academic recognition profile while remaining subject to independent verification and formal award evaluation.

References

  1. Elsevier. (n.d.). Scopus author details: Andrea Pisesky, Author ID 57219721692. Scopus.
    https://www.scopus.com/pages/authors/57219721692
  2. ORCID. (n.d.). ORCID record: Andrea Pisesky. ORCID.
    https://orcid.org/0000-0003-0094-0193
  3. Journal article(2021.). Adverse fibrosis remodeling and aortopulmonary collateral flow are associated with poor Fontan outcomes.
    https://doi.org/10.1186/s12968-021-00782-9
  4. Journal article(2021.). Cardiology and Cardiovascular Medicine. Standardisation of management after Norwood operation has not improved 1-year outcomes.
    https://doi.org/10.1017/S1047951120003376
  5. Cardiology and Cardiovascular Medicine. (2026.). International Cardiology and Cardiovascular Medicine event website.
    https://cardiology-conferences.pencis.com/

Emilia D’Elia | Heart Failure | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Best Researcher Award

Emilia D’Elia
ASST Papa Giovanni XXIII, Italy

Emilia D’Elia
Affiliation ASST Papa Giovanni XXIII
Country Italy
Scopus ID 40660899000
Documents 100
Citations 1,647
h-index 19
Subject Area Heart Failure
Event Cardiology and Cardiovascular Medicine
ORCID 0000-0002-6682-0074

Emilia D’Elia is a cardiovascular researcher affiliated with ASST Papa Giovanni XXIII in Italy, with a research profile focused on heart failure. The supplied bibliometric record reports 100 documents, 1,647 citations, and an h-index of 19, providing measurable indicators of scholarly productivity and visibility within cardiovascular medicine.[1]

Abstract

Emilia D’Elia is a cardiovascular researcher affiliated with ASST Papa Giovanni XXIII in Italy, with a documented research profile in heart failure. Available bibliometric information identifies 100 documents, 1,647 citations, and an h-index of 19, indicating sustained publication activity and measurable academic visibility. Her subject specialization places her work within contemporary cardiovascular medicine, where heart failure research addresses diagnosis, treatment, outcomes, and disease management. The profile provides a quantitative basis for considering research recognition while acknowledging that bibliometric indicators should be interpreted alongside publication quality, originality, clinical relevance, collaboration, and broader contributions to cardiovascular science and patient care.[1]

Keywords

Emilia D’Elia; heart failure; cardiology; cardiovascular medicine; clinical research; scholarly impact; bibliometrics; citations; h-index; cardiovascular outcomes; ASST Papa Giovanni XXIII; Italy; research recognition; Best Researcher Award.

Introduction

Heart failure is a major area of cardiovascular research requiring evidence across prevention, diagnosis, pharmacological management, device therapy, and long-term outcomes. Contemporary clinical guidance emphasizes multidisciplinary and evidence-based approaches to improving outcomes for affected patients.[2] Researchers specializing in heart failure contribute to the development and evaluation of clinically relevant evidence.

Research Profile

The supplied profile identifies Emilia D’Elia with ASST Papa Giovanni XXIII in Italy and associates her principal subject area with heart failure. Her Scopus author identifier is 40660899000, while the reported record comprises 100 documents, 1,647 citations, and an h-index of 19. These indicators describe a research profile with established bibliometric visibility.[1]

Research Contributions

The available information supports characterization of D’Elia’s research within heart failure and cardiovascular medicine. Research in this field can contribute to understanding disease mechanisms, improving risk assessment, evaluating therapeutic strategies, and strengthening evidence-based clinical care. The documented publication and citation record provides measurable evidence of sustained engagement with the scientific literature.[1]

Publications

The supplied Scopus information reports 100 documents associated with the researcher profile. Because individual publication titles, journals, publication years, and article-level identifiers were not provided, this article does not assign specific publications or DOIs without verification. The complete bibliographic record can be reviewed through the linked Scopus author profile.[1]

Research Impact

The reported 1,647 citations and h-index of 19 provide quantitative measures of scholarly influence within the indexed research record. Citation metrics can assist in evaluating research visibility, although they do not independently establish methodological quality, originality, clinical effectiveness, or societal benefit. A balanced assessment should therefore consider both bibliometric and qualitative evidence.[1]

Award Suitability

Based on the supplied information, Emilia D’Elia presents characteristics relevant to consideration for a Best Researcher Award in cardiology and cardiovascular medicine, particularly through her documented activity in heart failure research and established bibliometric record. Final award assessment should additionally consider originality, publication quality, research leadership, clinical relevance, collaboration, and independently verifiable achievements.

Conclusion

Emilia D’Elia’s supplied academic profile reflects sustained research activity in heart failure and cardiovascular medicine, supported by 100 reported documents, 1,647 citations, and an h-index of 19. These indicators provide a quantitative foundation for academic recognition, while a complete award evaluation should incorporate verified publication quality, scientific originality, clinical significance, and broader research contributions.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Emilia D’Elia, Author ID 40660899000. Scopus.
    https://www.scopus.com/pages/authors/40660899000
  2. Journal article (2025.). SGLT2 inhibitors and new frontiers in heart failure treatment regardless of ejection fraction and setting.
    https://doi.org/10.1093/eurheartjsupp/suae117
  3. Journal article. (2026.). Sex-related disparities in elderly patients with heart failure with mildly reduced or preserved ejection fraction.
    https://doi.org/10.1093/eschf/xvaf022
  4. Cardiology and Cardiovascular Medicine. (2026.). International Cardiology and Cardiovascular Medicine event website.
    https://cardiology-conferences.pencis.com/

Cedric Duval | Cardiovascular Researches | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Best Researcher Award

Cedric Duval
University of Leeds

Cedric Duval
Affiliation University of Leeds
Country United Kingdom
Scopus ID 55941091300
Documents 43
Citations 1,556
h-index 21
Subject Area Cardiovascular Researches
Event Cardiology and Cardiovascular Medicine
ORCID 0000-0002-4870-6542

Cedric Duval is presented as a researcher affiliated with the University of Leeds in the United Kingdom, with a stated subject area of cardiovascular research. The supplied academic profile records 43 documents, 1,556 citations, and an h-index of 21. These bibliometric indicators provide quantitative context for evaluating scholarly productivity and research visibility within cardiovascular science. [1]

Abstract

This profile presents Cedric Duval, affiliated with the University of Leeds, as a researcher working within cardiovascular research. The supplied academic indicators report 43 documents, 1,556 citations, and an h-index of 21, providing measurable evidence of publication activity and citation visibility. The profile considers these indicators alongside institutional affiliation, researcher identification information, and the proposed Best Researcher Award context. The assessment emphasizes documented scholarly output, research visibility, and relevance to cardiovascular science. Bibliometric values are presented as supplied and should be interpreted as time-sensitive indicators that may change as databases update records and citations. [1]

Keywords

Cedric Duval, cardiovascular research, cardiovascular medicine, University of Leeds, bibliometrics, scholarly publications, citation impact, h-index, research excellence, Best Researcher Award.

Introduction

Cardiovascular research encompasses scientific investigation into the mechanisms, prevention, diagnosis, treatment, and management of diseases affecting the heart and vascular system. Researchers in this field contribute through experimental studies, clinical investigations, translational research, and interdisciplinary approaches. Academic recognition commonly considers the quality and relevance of research together with evidence of scholarly productivity and influence. [2]

Research Profile

Cedric Duval is identified in the supplied information as being affiliated with the University of Leeds in the United Kingdom. The stated research subject area is cardiovascular research. The associated Scopus Author ID is 55941091300, while the supplied ORCID identifier is 0000-0002-4870-6542. Persistent researcher identifiers help distinguish scholarly records and support accurate attribution of publications across academic information systems. [1] [3]

Research Contributions

The available profile data indicate a sustained body of scholarly output, represented by 43 documents and substantial citation activity. Within cardiovascular research, contributions may be evaluated according to originality, methodological quality, scientific relevance, reproducibility, and potential clinical significance. The supplied bibliometric information provides quantitative context, while publication-level analysis would be required to establish the specific scientific findings and contributions associated with individual works. [1]

Publications

The supplied information attributes 43 documents to the researcher profile. This page does not assign individual article titles, journals, publication dates, or research findings that were not provided in the source information. The Scopus Author ID supplied for this profile can be used to review the indexed publication record, including documents, citations, co-authorship, subject classifications, and related bibliometric information. [1]

Research Impact

The supplied citation count of 1,556 and h-index of 21 indicate measurable visibility within the indexed scholarly record. Citation indicators can assist in describing research influence, although they should be interpreted alongside publication quality, field-specific citation practices, authorship contribution, and publication age. Accordingly, bibliometric measures are most appropriately treated as complementary evidence within a broader academic evaluation rather than as an independent measure of research quality. [1]

Award Suitability

Based on the supplied profile, Cedric Duval demonstrates characteristics relevant to consideration for a Best Researcher Award in cardiovascular research, including documented scholarly output, citation activity, and a stated specialization aligned with cardiovascular science. The reported 43 documents, 1,556 citations, and h-index of 21 provide quantitative evidence for consideration. Final award eligibility and selection should be determined according to the official criteria, verification procedures, and evaluation process established by the organizing body. [1] [4]

Conclusion

Cedric Duval is presented as a cardiovascular research scholar affiliated with the University of Leeds. The supplied bibliometric information records 43 documents, 1,556 citations, and an h-index of 21, providing a concise quantitative profile of scholarly activity. These indicators support consideration within an academic recognition framework, while a complete assessment should incorporate publication quality, research originality, contribution to cardiovascular science, and independently verified evidence.

References

  1. Elsevier. (n.d.). Scopus author details: Cedric Duval, Author ID 55941091300. Scopus.
    https://www.scopus.com/pages/authors/55941091300
  2. Journal article. (2026.) Fibrinogen wags its disordered tail: α chain and thrombosis.
    https://doi.org/10.1182/blood.2026033618
  3. ORCID. (n.d.). ORCID record: Cedric Duval, ORCID iD 0000-0002-4870-6542. ORCID.
    https://orcid.org/0000-0002-4870-6542
  4. Cardiology and Cardiovascular Medicine. (2026.). Academic recognition and award information.
    https://cardiology-conferences.pencis.com/

Radwa Mehanna | Cardiovascular Researches | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Best Researcher Award

Radwa Mehanna — Alexandria University, Egypt
Radwa Mehanna
Affiliation Alexandria University
Country Egypt
Scopus ID 55851530300
Documents 43
Citations 927
h-index 19
Subject Area Cardiovascular Researches
Event International Research Awards on Cardiology & Cardiovascular Medicine
ORCID 0000-0001-9048-4464

Radwa Mehanna is a Professor of Medical Physiology at Alexandria University whose scholarly work connects cardiovascular biology, regenerative medicine, cardiac stem cells, extracellular vesicles, and mechanisms of tissue injury. Her research profile includes cellular approaches to cardiovascular recovery, regenerative strategies, and cardiovascular awareness, reflecting an interdisciplinary orientation within contemporary biomedical science. Her documented publications provide review, experimental, and translational perspectives relevant to cardiovascular research and regenerative medicine. [3]

Abstract

Radwa Mehanna is a Professor of Medical Physiology at Alexandria University whose research connects cardiovascular biology, regenerative medicine, cardiac stem cells, extracellular vesicles, and mechanisms of tissue injury. Her publications address cardiac stem cell biology, ischemic-reoxygenation stress, cardiovascular risk awareness, and therapeutic approaches relevant to cardiovascular recovery. Recent work has examined small extracellular vesicles and their capacity to improve survival of cardiac stem cells under oxidative stress, while earlier scholarship reviewed the biology and future prospects of cardiac stem cells. These contributions place regenerative and translational physiology within broader cardiovascular research, supporting scientific discussion of myocardial protection, repair, and innovation. [4]

Keywords

Cardiac stem cells; extracellular vesicles; ischemic-reoxygenation injury; regenerative medicine; cardiovascular risk; myocardial protection; cardiac repair; stem cell biology; translational cardiovascular research; medical physiology.

Introduction

Radwa Mehanna’s scholarly profile reflects an interdisciplinary approach linking medical physiology with regenerative medicine and cardiovascular science. At Alexandria University, her research has included cardiac stem cells, extracellular vesicles, ischemic-reoxygenation injury, cardiovascular risk, and public awareness. Her publications demonstrate sustained engagement with mechanisms of cardiac repair and translational research questions. [1][2]

Research Profile

Mehanna is affiliated with the Faculty of Medicine at Alexandria University associated with the Center of Excellence for Research in Regenerative Medicine and Applications. Public scholarly records identify her as a Professor of Medical Physiology, with research interests spanning stem cells, cell culture, cardiovascular risk, electrocardiography, and regenerative medicine approaches. [1]

Research Contributions

Her research examines cardiac stem-cell biology and regenerative mechanisms. Her 2022 review examined current knowledge and future prospects for cardiac stem cells, while later research investigated small extracellular vesicles supporting Sca-1-positive cardiac stem-cell survival during ischemic-reoxygenation injury. These publications connect cellular mechanisms with potential cardiovascular repair strategies in translational research. [2][3]

Publications

Mehanna has contributed publications on cardiac stem cells and extracellular vesicles. Her 2022 World Journal of Stem Cells review examined cardiac stem-cell biology and therapeutic prospects. A 2025 Biological Research article examined extracellular vesicle protection of cardiac stem cells, while a 2021 European Heart Journal Supplements contribution addressed awareness. [2][3]

Research Impact

The research has relevance to cardiovascular regenerative medicine through investigation of cardiac stem cells and extracellular vesicles as mechanisms for cellular protection and tissue recovery. Her publications provide review, experimental, and public-health perspectives, helping connect laboratory physiology with cardiovascular prevention and repair. The work contributes to translational research and multidisciplinary research. [2][3][4]

Award Suitability

Mehanna’s profile is suitable for consideration for a Best Researcher Award in cardiovascular research because her documented work spans cardiac stem-cell biology, regenerative medicine, ischemic-reoxygenation injury, and cardiovascular awareness. Review and experimental research demonstrate breadth across foundational questions. Award assessment should consider verified publication quality, citation records, leadership, and contributions. [1][2]

Conclusion

Radwa Mehanna’s record demonstrates a research trajectory connecting physiology, regenerative medicine, and cardiovascular science. Her work on cardiac stem cells and extracellular vesicles is particularly relevant to emerging strategies for myocardial protection and repair, while cardiovascular awareness research broadens the translational perspective. Her documented contributions provide a basis for recognition. [2][3][4]

References

  1. Egyptian Society of Extracellular Vesicles. (n.d.). Prof. Radwa Mehanna: Board profile and biography. Egyptian Society of Extracellular Vesicles.
    https://esev-eg.org/board/
  2. Mehanna, R. A., et al. (2022). Cardiac stem cells: Current knowledge and future prospects. World Journal of Stem Cells, 14(1), 1–40.
    https://doi.org/10.4252/wjsc.v14.i1.1
  3. Mehanna, R. A., et al. (2025). Small extracellular vesicles enhance the survival of Sca-1+ cardiac stem cells against ROS-induced ischemic-reoxygenation injury in vitro. Biological Research, 58, 12.
    https://doi.org/10.1186/s40659-025-00593-7
  4. Mehanna, R. (2021). Role of Awareness Activities in Mega-Events. European Heart Journal Supplements, 23(Supplement_D), suab069.019.
    https://doi.org/10.1093/eurheartj/suab069.019
  5. Barachini, S., Ghelardoni, S., Varga, Z. V., Mehanna, R. A., et al. (2023). Antineoplastic drugs inducing cardiac and vascular toxicity — An update. Vascular Pharmacology, 153, 107223.
    https://doi.org/10.1016/j.vph.2023.107223

Ersilia Nigro | Cardiovascular Researches | Innovative Research Award

Published on by Cardiology and Cardiovascular Medicine

Innovative Research Award

Ersilia Nigro
Università della Campania Vanvitelli, Italy

Ersilia Nigro
Affiliation Università della Campania Vanvitelli
Country Italy
Scopus ID 57194323816
Documents 119
Citations 3,964
h-index 33
Subject Area Cardiovascular Researches
Event International Research Awards on Cardiology & Cardiovascular Medicine
ORCID 0000-0001-5637-1685

The Innovative Research Award recognizes the scholarly contributions of Ersilia Nigro, an Italian researcher affiliated with Università della Campania Vanvitelli, whose work has advanced knowledge in cardiovascular and metabolic sciences. Her interdisciplinary research explores adipokines, inflammatory biomarkers, exercise physiology, metabolic dysfunction, and lifestyle-related determinants of cardiovascular health. With an established publication record, a Scopus h-index of 33, and nearly four thousand citations, her investigations have contributed to translational approaches linking molecular mechanisms with clinical practice.[1]

Abstract

This article summarizes the scientific profile of Ersilia Nigro in relation to the Innovative Research Award. Her work integrates molecular cardiology, metabolism, and preventive medicine, emphasizing biomarkers associated with obesity, inflammation, exercise adaptation, and cardiovascular risk. Current research demonstrates sustained engagement with emerging topics including adiponectin signaling, orexin regulation, muscle wasting, and cardiometabolic interventions.[2]

Keywords

Cardiovascular research; adipokines; exercise physiology; obesity; inflammation; cardiometabolic health; translational medicine; biomarkers.

Introduction

Contemporary cardiovascular science increasingly relies on multidisciplinary investigations connecting lifestyle behaviors with molecular pathways. Nigro’s research addresses this need by examining how exercise, nutrition, sleep, and metabolic dysfunction influence cardiovascular outcomes and chronic disease progression.[3]

Research Profile

Her publication portfolio spans clinical, translational, and experimental studies. Indexed in Scopus with 119 documents and 3,964 citations, her scholarship demonstrates sustained influence across cardiovascular medicine, endocrinology, and metabolic research. Collaborative investigations frequently examine biomarker-driven approaches to patient stratification and disease management.[1]

Research Contributions

  • Investigation of adiponectin isoforms and inflammatory biomarkers in chronic diseases.
  • Evaluation of exercise interventions and their effects on cardiometabolic health.
  • Analysis of lifestyle factors, including sleep and nutrition, in cardiovascular regulation.
  • Research on muscle wasting, dyslipidemia, and patient management strategies in chronic respiratory disorders.

Publications

Recent publications include studies on irisin responses in obese middle-aged males, exercise-induced modulation of adiponectin, orexin and lifestyle habits, COPD-associated muscle wasting, and inflammatory markers in Crohn’s disease.[4]

Research Impact

The impact of Nigro’s work is reflected in extensive citation activity and the adoption of biomarker-based approaches within cardiometabolic research. Her studies support evidence-informed strategies for prevention, risk assessment, and personalized interventions targeting obesity-related cardiovascular conditions.[5]

Award Suitability

The Innovative Research Award acknowledges scientific originality, interdisciplinary collaboration, and measurable influence. Nigro’s sustained contributions across cardiovascular medicine, molecular biology, and preventive health align with these criteria through a record of peer-reviewed outputs, translational relevance, and international visibility.[6]

Conclusion

Ersilia Nigro has established a significant research profile at the intersection of cardiovascular science and metabolism. Her investigations continue to inform understanding of biomolecular pathways underlying cardiometabolic disorders while advancing preventive and therapeutic perspectives relevant to contemporary healthcare challenges.

References

  1. Elsevier. (n.d.). Scopus author details: Ersilia Nigro, Author ID 57194323816. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57194323816
  2. Nigro, E., et al. (2026). Effects of Two Different Training Programs on Cardiometabolic Health, Body Composition and Irisin in Middle Age Obese Males: A Pilot Study. Life.
    DOI: https://doi.org/10.3390/life16040657
  3. Nigro, E., et al. (2025). Orexin and Lifestyle Habits: A Meaningful Connection Among Nutrition, Physical Activity, and Sleep Pattern in Health and Diseases. International Journal of Molecular Sciences.
    DOI: https://doi.org/10.3390/ijms26188980
  4. Nigro, E., et al. (2026). Acute Resistance Exercise Temporarily Reduces Circulating Adiponectin in Trained Young Men: A Pilot Study. Biomolecules. DOI: https://doi.org/10.3390/biom16020229
  5. Nigro, E., et al. (2025). Muscle Wasting and Treatment of Dyslipidemia in COPD: Implications for Patient Management. Biomedicines.
    DOI: https://doi.org/10.3390/biomedicines13081817
  6. Nigro, E., et al. (2025). Adiponectin and HMW Oligomers in Relation to Inflammatory Markers in Crohn’s Disease Patients. Biomedicines.
    DOI: https://doi.org/10.3390/biomedicines13020273

Runze Wen | Cardiac Imaging | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Runze Wen | Cardiac Imaging | Best Researcher Award

The First Affiliated Hospital of University of Science and Technology | China

Dr. Runze Wen is an emerging scholar in the field of Cardiac Nuclear Medicine, currently pursuing his doctoral degree at the University of Science and Technology of China. His research focuses on advancing nuclear imaging techniques for cardiovascular diagnostics, with a strong emphasis on enhancing the precision and clinical applicability of cardiac assessments. Despite being at an early stage in his academic career, Dr. Wen has already demonstrated remarkable productivity and impact within the scientific community, with 3 published documents, 13 citations across 13 referencing works, and an h index of 3, a clear indication of the relevance and influence of his research. His investigations often integrate nuclear imaging modalities with innovative diagnostic approaches to improve the understanding of coronary microvascular dysfunction and other complex cardiac conditions. In addition to his academic achievements, Dr. Wen is a Fellow in Training (FIT) member of the American College of Cardiology (ACC), reflecting his commitment to professional development and international collaboration within the cardiology field. His ability to bridge advanced imaging science with clinical cardiology has earned him recognition as a promising young researcher dedicated to transforming cardiovascular diagnostics. Through his ongoing research and active engagement in academic circles, Dr. Runze Wen continues to contribute meaningfully to the future of nuclear cardiology, aiming to enhance patient care through evidence based innovation and interdisciplinary research excellence.

Profiles: Scopus | Orcid

Featured Publications

Wen, R., Xie, Q., Pan, B., Ni, M., Zhu, X., Meng, X., Wei, Z., Wu, X., Li, D., & Wang, X. (2025). Simultaneous 13N-ammonia and gadolinium perfusion using integrated PET–MRI: Diagnostic accuracy in coronary microvascular dysfunction. Frontiers in Medicine

Wen, R., Zhao, M., Chen, C., Yang, Y., & Zhang, B. (2023). A novel nomogram integrated with preablation stimulated thyroglobulin and thyroglobulin/thyroid-stimulating hormone ratio to predict the therapeutic response of intermediate- and high-risk differentiated thyroid cancer patients: A bi-center retrospective study.

Caicai Xi | Cardiovascular Researches | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Prof. Caicai Xi | Cardiovascular Researches | Best Researcher Award

Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University | China

Prof. Caicai Xi is a postdoctoral fellow at the College of Life Sciences, Zhejiang University, and holds a doctoral degree from Nanjing University of Chinese Medicine. Her research expertise lies in the total synthesis, extraction, separation, and biological evaluation of natural products derived from traditional Chinese medicine (TCM). She has also made significant contributions to the fields of production and synthetic biology of TCM resources, pharmacological and active material basis studies of TCM compound serum, and the development of hospital preparations and new drug formulations. Prof. Xi’s research aims to promote the rational utilization, modernization, and industrial application of TCM resources through scientific innovation and interdisciplinary integration. She has published 15 academic papers, which have collectively received 137 citations, and her work is reflected in an h-index of 3, indicating a growing academic impact in her area of specialization. Beyond her research publications, Prof. Xi has presided over and participated in 11 scientific research projects, contributed to the drafting of one technical standard, and co-authored one academic monograph. Recognized as a High-level Talent (Class E) in Zhejiang Province and Hangzhou City, she also holds positions in national professional organizations dedicated to TCM research and innovation. Her active participation in these scientific communities underscores her commitment to advancing the modernization and global relevance of traditional Chinese medicine through innovative research and collaborative development.

Profile: Scopus

Featured Publication

Wu, R., Wang, J., Zhou, H., Xue, X., Tong, C., Zhao, L., Wu, Y., Mei, X., Guo, Z., & Xi, C. (2025). Analysis of blood components and target prediction for the combined use of Dendrobium officinale compound and Western medicine in antihypertensive therapy based on network pharmacology and molecular docking. Drug Design, Development and Therapy

Ibtasam Wajid | Cardiovascular Diseases | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Mr. Ibtasam Wajid | Cardiovascular Diseases | Best Researcher Award

Shenzhen University | China

Mr. Ibtasam Wajid is an emerging researcher whose work focuses on the intersection of biomedical engineering, health informatics, and data science, with a particular interest in developing innovative machine learning and deep learning models for improving healthcare outcomes. His research explores how advanced computational techniques can be applied to disease prediction, medical imaging, and clinical decision support, contributing to the growing field of digital health transformation. With an academic background spanning biochemistry, health informatics, and biomedical research, he brings an interdisciplinary perspective to addressing complex challenges in modern medicine. He has authored three research documents, accumulating a total of six citations and holding an h-index of one, reflecting a steadily growing research impact at an early stage of his academic career. Alongside his research contributions, he has actively participated in mentoring undergraduate students, organizing technical workshops, and promoting collaborative learning environments within the scientific community. His ongoing studies and projects continue to focus on integrating artificial intelligence into healthcare systems to enhance accuracy, efficiency, and patient-centered care. Through his dedication to continuous learning and innovation, he demonstrates the potential to make lasting contributions to biomedical science and the advancement of data-driven healthcare solutions worldwide.

Profiles: Scopus | Google Scholar

Featured Publications

Sultan, H., Javed, I., Zubair, M., Iqbal, K., Bilal, M., Iqbal, J., & Wajid, I. (2021). Protein and polysaccharide-based biomaterial for the formation of composite bone scaffold. AlQalam Journal of Medical and Applied Sciences, 4(2), 80–88.

Wajid, I., Dan, L., & Wang, Q. (2025). Hybrid ensemble approaches for cardiovascular disease prediction: Leveraging interpretable AI for clinical insight. Intelligence-Based Medicine, 100297.

Ishaq, S., Afzal, S., Usmani, S. A., Wajid, I., Aziz, A., Tahir, R., Ahmad, A., & Ullah, A. (2025). Inflammatory cell death and leukemia treatment. Critical Reviews in Oncology/Hematology, 104909.